Related Experiment Videos
Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival
D M Nanus1, B J Schmitz-Dräger, R J Motzer
1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, N.Y.
Journal of the National Cancer Institute
|October 6, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
UNITY: A low-field magnetic resonance neuroimaging initiative to characterize neurodevelopment in low and middle-income settings.
Developmental cognitive neuroscience·2024
[Rational follow-up of non-muscle invasive bladder cancer].
Der Urologe. Ausg. A·2021
A Signal Through the Noise: Do Professionalism Concerns Impact the Decision Making of Competence Committees?
Academic medicine : journal of the Association of American Medical Colleges·2019
STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction.
BJOG : an international journal of obstetrics and gynaecology·2019
Pain and functional trajectories in symptomatic knee osteoarthritis over up to 12 weeks of exercise exposure.
Osteoarthritis and cartilage·2018
Timing of mental disorders in relation to cancer-specific mortality in cancer patients.
Journal of the National Cancer Institute·2026
Addressing the impact of tobacco and alcohol use on cancer-related health outcomes.
Journal of the National Cancer Institute·2026
Epigenetic aging of colorectal mucosa in cancer development.
Journal of the National Cancer Institute·2026
Randomized trial of adjuvant 5-FU-platinum vs paclitaxel-platinum for high-risk penile cancer.
Journal of the National Cancer Institute·2026
Evaluating longitudinal toxicity and adverse event in cetuximab-treated metastatic colorectal cancer: a pooled analysis from 1,302 patients in ARCAD database.
Journal of the National Cancer Institute·2026
Brain Network Convergence of Abnormal Gray Matter and Functional Activity of Pathological Dissociative Symptoms.
Psychiatry and clinical neurosciences·2026
SHMT2: a Metabolic and Immune Biomarker of Aggressive Lung Adenocarcinoma.
Journal of visualized experiments : JoVE·2026